CVS Health Corporation (CVS): Jim Cramer Says You Don't Want Them Buying The Wrong Robots

We recently published a list of Jim Cramer Discusses Melting Trade Tensions & These 12 Stocks. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other stocks that Jim Cramer discusses.

CVS Health Corporation (NYSE:CVS) is one of the largest pharmaceutical retailers in America. The firm’s shares have gained 44% year-to-date due to weakness at the firm’s primary rival Walgreens. Cramer’s previous remarks about CVS Health Corporation (NYSE:CVS) have praised the firm’s CEO and his turnaround efforts. The shares gained 4% in May after the firm raised its 2025 profit forecast to a midpoint of $6.10 per share from an earlier $5.87 per share. CVS Health Corporation (NYSE:CVS)’s turnaround efforts which have seen the firm appoint a new CEO and exit its Obamacare direct sales business have contributed to the strong 2025 share price performance. In his recent comments about CVS Health Corporation (NYSE:CVS), Cramer wondered what would happen if the firm automated its pharmacies through robots:

“I mean one of the things that is really meant to be changing here is healthcare. And you don’t want, uh, CVS, for instance, if they were to buy a robot, you don’t want them saying, do remember that scene, It’s a Wonderful Life, where the pharmacist gave them the wrong prescription? You don’t want that. You don’t want It’s a Wonderful Life, to be your life.”

In his previous comments, the CNBC host praised the firm’s management. Here’s what he said:

“Now we’ve got some healthcare, some issues to talk about on Thursday, that’s right, and these are anything but common steady healthcare companies…. There’s CVS, which is under new management, put up some really good numbers, and it’s just, that’s in health insurance, but also it’s core drugstore business, which they’ve closed, all the under performers… As for CVS, the health insurers have taken it on the chin of late. UnitedHealth and Centene both missed expectations. I bet Aetna sticks it.”

Overall, CVS ranks 11th on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.